Pred Forte

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Prednisolone acetate 1%{relative};  

Pieejams no:

AbbVie Limited

SNN (starptautisko nepatentēto nosaukumu):

Prednisolone acetate 1% w/v

Deva:

1 %

Zāļu forma:

Eye drops, solution

Kompozīcija:

Active: Prednisolone acetate 1%{relative}   Excipient: Benzalkonium chloride Boric acid Hydrochloric acid Hypromellose Polysorbate 80 Purified water Sodium chloride Sodium citrate dihydrate Sodium edetate Sodium hydroxide

Vienības iepakojumā:

Bottle, dropper, 5 mL

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Sanofi Chimie

Ārstēšanas norādes:

PRED FORTE® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.

Produktu pārskats:

Package - Contents - Shelf Life: Bottle, dropper, - 5 mL - 24 months from date of manufacture stored at or below 25°C 4 weeks opened stored at or below 25°C

Autorizācija datums:

1975-07-10

Produkta apraksts

PRED FORTE
®
(prednisolone acetate) 1.0% w/v Datasheet Version 5.0 CCDS v4.0 30 May
2023
1
NEW ZEALAND DATA SHEET
1. PRODUCT NAME
PRED FORTE
®
1.0% w/v ophthalmic suspension
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Prednisolone acetate 1.0% w/v (microfine suspension)
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
A topical anti-inflammatory ophthalmic suspension.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
PRED FORTE
®
is indicated for the treatment of steroid-responsive inflammation of
the
palpebral and bulbar conjunctiva, cornea and anterior segment of the
globe.
4.2 DOSE AND METHOD OF ADMINISTRATION
SHAKE WELL BEFORE USING.
Instil one drop into the conjunctival sac two to four times daily.
During the initial 24 to 48
hours, the dosing frequency may be increased if necessary. Care should
be taken not to
discontinue therapy prematurely.
If signs and symptoms fail to improve after 2 days, the patient should
be re-evaluated (see
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
).
_USE IN CHILDREN _
Safety and effectiveness in paediatric patients have not been
established.
Do not give to a child less than 12 years old as this medicine
contains boron and may impair
fertility in the future.
_ _
_USE IN THE ELDERLY: _
No overall differences in safety or effectiveness has been observed
between elderly and young
patients.
4.3 CONTRAINDICATIONS
PRED FORTE
®
suspension is contraindicated in:
•
most viral diseases of the cornea and conjunctiva including
superficial or epithelial
herpes simplex keratitis (dendritic keratitis), vaccinia and
varicella,
•
mycobacterial infection such as tuberculosis of the eye,
•
fungal diseases of ocular structures,
PRED FORTE
®
(prednisolone acetate) 1.0% w/v Datasheet Version 5.0 CCDS v4.0 30 May
2023
2
•
individuals with known or suspected hypersensitivity to the active
substance or to any
of the excipients listed in section 6.1and to other corticosteroids.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
WARNINGS:
Prolonged use of corticosteroids may